Tripping out: the highs and lows of psychedelic therapy
‘The strongest evidence is currently for addiction, then depression and anxiety, followed by moderate evidence for obsessive compulsive disorder (OCD),’ says Professor David Nutt, a psychiatrist and neuropsychopharmacologist I speak to for advice, and who has pioneered the research. ‘In a study we published in The Lancet, one dose of psilocybin, found in magic mushrooms,…
Recent Comments